1. Home
  2. IRIX vs VVOS Comparison

IRIX vs VVOS Comparison

Compare IRIX & VVOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • VVOS
  • Stock Information
  • Founded
  • IRIX 1989
  • VVOS 2016
  • Country
  • IRIX United States
  • VVOS United States
  • Employees
  • IRIX N/A
  • VVOS N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • VVOS Medical Specialities
  • Sector
  • IRIX Health Care
  • VVOS Health Care
  • Exchange
  • IRIX Nasdaq
  • VVOS Nasdaq
  • Market Cap
  • IRIX 16.5M
  • VVOS 18.5M
  • IPO Year
  • IRIX 1996
  • VVOS 2020
  • Fundamental
  • Price
  • IRIX $1.22
  • VVOS $2.63
  • Analyst Decision
  • IRIX Hold
  • VVOS Strong Buy
  • Analyst Count
  • IRIX 1
  • VVOS 2
  • Target Price
  • IRIX $2.00
  • VVOS $6.10
  • AVG Volume (30 Days)
  • IRIX 98.8K
  • VVOS 99.9K
  • Earning Date
  • IRIX 05-13-2025
  • VVOS 05-13-2025
  • Dividend Yield
  • IRIX N/A
  • VVOS N/A
  • EPS Growth
  • IRIX N/A
  • VVOS N/A
  • EPS
  • IRIX N/A
  • VVOS N/A
  • Revenue
  • IRIX $48,669,000.00
  • VVOS $15,031,000.00
  • Revenue This Year
  • IRIX $9.61
  • VVOS $23.17
  • Revenue Next Year
  • IRIX N/A
  • VVOS $25.23
  • P/E Ratio
  • IRIX N/A
  • VVOS N/A
  • Revenue Growth
  • IRIX N/A
  • VVOS 8.91
  • 52 Week Low
  • IRIX $0.78
  • VVOS $1.91
  • 52 Week High
  • IRIX $3.25
  • VVOS $6.28
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 62.01
  • VVOS 48.74
  • Support Level
  • IRIX $0.98
  • VVOS $1.98
  • Resistance Level
  • IRIX $1.26
  • VVOS $2.71
  • Average True Range (ATR)
  • IRIX 0.09
  • VVOS 0.24
  • MACD
  • IRIX 0.04
  • VVOS 0.08
  • Stochastic Oscillator
  • IRIX 91.49
  • VVOS 89.04

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Share on Social Networks: